Search
for
Sort by
Research 121–150 of 166
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Does an apple a day keep away diseases? Evidence and mechanism of action
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Dermatologic Adverse Events from Cancer Treatments
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Alopecia in Children with Cancer: A Review from Pathophysiology to Management
- <i>Nigella sativa</i> and its nano‐mediated approach toward management of neurodegenerative disorders: A review
- Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil
- Antioxidant and Antiproliferative Activity of Finasteride against Glioblastoma Cells
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Chemotherapy and Cutaneous Drug Reactions
- Approach to the patient with hair loss
- Treatment of Chemotherapy Induced Alopecia
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Camellia japonica seed extract promotes hair growth by preventing dermal papilla cell senescence and activating hair follicle stem cells
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy